UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 30, 2009
VITRO DIAGNOSTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
| | |
Nevada | 0-17378 | 84-1012042 |
(State or other jurisdiction
of incorporation) | Commission File
Number | (I.R.S. Employer Identification number) |
4621 Technology Drive, Golden CO 80403
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 999-2130
______________________________________________________
(Former name or former address, if changed since last report)
| |
___ | Written communications pursuant to Rule 425 under the Securities Act |
___ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
| |
ITEM 7.01 | REGULATION FD DISCLOSURE |
On December 30, 2009, the Company issued a press release announcing the completion of a private placement of its common stock and warrants. A copy of the press release is attached hereto as Exhibit 99.1
ITEM 9.01: EXHIBITS
| | |
| | (c) | Exhibit |
| | | |
| | Item | Title |
| | | |
| | 99.1 | Press Release dated December 30, 2009. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
| | | Vitro Diagnostics, Inc.
(Registrant) |
| | | | |
| | Dated: December 30, 2009 | | ___/s/ James R. Musick_____
James R. Musick, President and Chief Executive Officer |
| | | | |
3
